Literature DB >> 22976140

Effectiveness of maximal safe resection for glioblastoma including elderly and low Karnofsky performance status patients: retrospective review at a single institute.

Takeo Uzuka1, Hiroshi Aoki, Manabu Natsumeda, Hideaki Takahashi, Yukihiko Fujii.   

Abstract

Elderly and low Karnofsky performance status (KPS) patients have been excluded from most prospective trials. This retrospective study investigated glioblastoma treatment outcomes, including those of elderly and low KPS patients, and analyzed the prognostic factors using the medical records of 107 consecutive patients, 59 men and 48 women aged from 21 to 85 years (median 65 years), with newly diagnosed glioblastoma treated at our institute. There were 71 high-risk patients with age >70 years and/or KPS <70%. Based on the extent of resection, the patients were classified into 3 groups: more than subtotal resection (subtotal, n = 44), partial resection (partial, n = 29), and biopsy only (biopsy, n = 34). Median overall survival (OS) of all 107 patients was 13.5 months. Median OS was 13.2 months in the high-risk group. Median OSs were 15.8, 12.8, and 12.1 months in the subtotal, partial, and biopsy groups, respectively. Multivariate analysis of 73 patients in the subtotal and partial groups found age ≤65 years (p = 0.047), 60 Gy irradiation (p = 0.009), O(6)-methylguanine-deoxyribonucleic acid methyltransferase-negative (p = 0.027), and more than subtotal removal (p = 0.003) were significant prognostic factors. The median postoperative KPS score tended to be better than the preoperative score, even in the high-risk group. We recommend maximal safe resection for glioblastoma patients, even those with advanced age and/or with low KPS scores.

Entities:  

Mesh:

Year:  2012        PMID: 22976140     DOI: 10.2176/nmc.52.570

Source DB:  PubMed          Journal:  Neurol Med Chir (Tokyo)        ISSN: 0470-8105            Impact factor:   1.742


  4 in total

1.  Is a pretreatment radiological staging system feasible for suggesting the optimal extent of resection and predicting prognosis in glioblastoma? An observational study.

Authors:  Jaume Capellades; Josep Puig; Sira Domenech; Teresa Pujol; Laura Oleaga; Angels Camins; Carles Majós; Rocio Diaz; Christian de Quintana; Pilar Teixidor; Gerard Conesa; Gerard Plans; Josep Gonzalez; Natalia García-Balañà; Jose Maria Velarde; Carmen Balaña
Journal:  J Neurooncol       Date:  2017-12-28       Impact factor: 4.130

2.  The Impact of Perioperative Arterial Infarct on Recurrence, Functional Outcomes, and Survival in Glioblastoma Patients.

Authors:  Jakob T Lupa; Jeffrey J Raizer; Irene B Helenowski; Benjamin P Liu; Kartik Kesavabhotla; Matthew C Tate
Journal:  Front Oncol       Date:  2020-05-13       Impact factor: 6.244

3.  Prognostic value of tumour volume in patients with a poor Karnofsky performance status scale - a bicentric retrospective study.

Authors:  Melanie Barz; Julia Gerhardt; Stefanie Bette; A Kaywan Aftahy; Thomas Huber; Stephanie E Combs; Yu-Mi Ryang; Benedikt Wiestler; Marco Skardelly; Irina Gepfner-Tuma; Felix Behling; Friederike Schmidt-Graf; Bernhard Meyer; Jens Gempt
Journal:  BMC Neurol       Date:  2021-11-15       Impact factor: 2.474

Review 4.  Association of the Extent of Resection With Survival in Glioblastoma: A Systematic Review and Meta-analysis.

Authors:  Timothy J Brown; Matthew C Brennan; Michael Li; Ephraim W Church; Nicholas J Brandmeir; Kevin L Rakszawski; Akshal S Patel; Elias B Rizk; Dima Suki; Raymond Sawaya; Michael Glantz
Journal:  JAMA Oncol       Date:  2016-11-01       Impact factor: 31.777

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.